Challenges in pediatric renal transplantation

Area of Science:

• Pediatric nephrology
• Transplant immunology
• Immunosuppression

Background:

• Kidney transplantation is the optimal treatment for end-stage renal disease in children.
• Significant advancements have reduced early acute rejection and graft loss in pediatric kidney recipients over the past 25 years.
• Long-term graft survival and patient morbidity remain challenges, necessitating novel immunosuppressive strategies.

Purpose of the Study:

• To explore advancements in immunosuppressive regimens for pediatric kidney transplantation.
• To address the challenges of achieving graft tolerance and minimizing side effects in pediatric recipients.
• To highlight ongoing research in diagnosing anti-HLA antibodies and managing immunized subjects for improved transplant outcomes.

Main Methods:

• Review of recent modifications in immunosuppressive therapy, including steroid and calcineurin inhibitor minimization.
• Inclusion of new induction drugs in treatment protocols.
• Examination of novel diagnostic methods for anti-HLA antibodies and treatment protocols for immunized pediatric patients.

Main Results:

• Implementation of modified immunosuppressive protocols, including drug minimization, has been observed.
• Introduction of new induction agents aims to enhance transplant success.
• Development of improved diagnostic tools and protocols for managing sensitized or immunized pediatric candidates.

Conclusions:

• Optimizing immunosuppression is crucial for enhancing long-term graft survival and reducing morbidity in pediatric kidney transplant recipients.
• Minimizing side effects while maintaining graft tolerance is a key objective.
• Advances in antibody detection and management strategies offer promising avenues for improving outcomes in challenging pediatric transplant cases, particularly in immunized individuals.